Regulation of NF-κB signaling by the A20 deubiquitinase (original) (raw)

• Hayden MS, Ghosh S . Shared principles in NF-κB signaling. Cell 2008; 132: 344–362.
  CAS PubMed Google Scholar
• Hayden MS, Ghosh S . Signaling to NF-κB. Genes Dev 2004; 18: 2195–2224.
  CAS PubMed Google Scholar
• Hacker H, Karin M . Regulation and function of IKK and IKK-related kinases. Sci STKE 2006; 2006: re13.
  PubMed Google Scholar
• Sun SC, Ganchi PA, Ballard DW, Greene WC . NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 1993; 259: 1912–1915.
  CAS PubMed Google Scholar
• Hershko A, Ciechanover A . The ubiquitin system. Annu Rev Biochem 1998; 67: 425–479.
  CAS PubMed Google Scholar
• Bernassola F, Karin M, Ciechanover A, Melino G . The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008; 14: 10–21.
  CAS PubMed Google Scholar
• Ikeda F, Dikic I . Atypical ubiquitin chains: new molecular signals. ‘Protein modifications: beyond the usual suspects' review series. EMBO Rep 2008; 9: 536–542.
  CAS PubMed PubMed Central Google Scholar
• Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 2009; 11: 123–132.
  CAS PubMed Google Scholar
• Iwai K, Tokunaga F . Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep 2009; 10: 706–713.
  CAS PubMed PubMed Central Google Scholar
• Ikeda F, Deribe YL, Skånland SS, Stieglitz B, Grabbe C, Franz-Wachtel M et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 2011; 471: 637–641.
  CAS PubMed PubMed Central Google Scholar
• Deng L, Wang C, Spencer E, Yang L, Braun A, You J et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103: 351–361.
  CAS PubMed Google Scholar
• Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J 2010; 29: 4198–4209.
  CAS PubMed PubMed Central Google Scholar
• Matsumoto ML, Wickliffe KE, Dong KC, Yu C, Bosanac I, Bustos D et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010; 39: 477–484.
  CAS PubMed Google Scholar
• Chastagner P, Israel A, Brou C . AIP4/Itch regulates Notch receptor degradation in the absence of ligand. PLoS ONE 2008; 3: e2735.
  PubMed PubMed Central Google Scholar
• Wertz IE, Dixit VM . Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev 2008; 19: 313–324.
  CAS PubMed Google Scholar
• O'Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT . Ubiquitination of RIP1 regulates an NF-κB-independent cell-death switch in TNF signaling. Curr Biol 2007; 17: 418–424.
  CAS PubMed PubMed Central Google Scholar
• Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011; 471: 591–596.
  CAS PubMed Google Scholar
• Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A et al. TAB2 and TAB3 actvate the NF-κB pathway through binding to polyubiquitin chains. Mol Cell 2004; 15: 535–548.
  CAS PubMed Google Scholar
• Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ . Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245–257.
  CAS PubMed Google Scholar
• Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ . TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346–351.
  CAS PubMed Google Scholar
• Akira S . Toll-like receptor signaling. J Biol Chem 2003; 278: 38105–38108.
  CAS PubMed Google Scholar
• Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X . Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 2002; 22: 7158–7167.
  CAS PubMed PubMed Central Google Scholar
• Reyes-Turcu FE, Ventii KH, Wilkinson KD . Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 2009; 78: 363–397.
  CAS PubMed Google Scholar
• Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123: 773–786.
  CAS PubMed Google Scholar
• Ambroggio XI, Rees DC, Deshaies RJ . JAMM: a metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol 2004; 2: E2.
  PubMed Google Scholar
• Komander D, Clague MJ, Urbe S . Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10: 550–563.
  CAS PubMed Google Scholar
• Harhaj EW, Dixit VM . Deubiquitinases in the regulation of NF-κB signaling. Cell Res 2011; 21: 22–39.
  CAS PubMed Google Scholar
• Sun SC . CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ 2010; 17: 25–34.
  CAS PubMed Google Scholar
• Opipari AW Jr, Boguski MS, Dixit VM . The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990; 265: 14705–14708.
  CAS PubMed Google Scholar
• Krikos A, Laherty CD, Dixit VM . Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by κB elements. J Biol Chem 1992; 267: 17971–17976.
  CAS PubMed Google Scholar
• Laherty CD, Perkins ND, Dixit VM . Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J Biol Chem 1993; 268: 5032–5039.
  CAS PubMed Google Scholar
• Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM . The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424–12427.
  CAS PubMed Google Scholar
• Jaattela M, Mouritzen H, Elling F, Bastholm L . A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 1996; 156: 1166–1173.
  CAS PubMed Google Scholar
• Song HY, Rothe M, Goeddel DV . The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc Natl Acad Sci USA 1996; 93: 6721–6725.
  CAS PubMed PubMed Central Google Scholar
• Heyninck K, de Valck D, Vanden Berghe W, van Criekinge W, Contreras R, Fiers W et al. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J Cell Biol 1999; 145: 1471–1482.
  CAS PubMed PubMed Central Google Scholar
• Heyninck K, Beyaert R . The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6. FEBS Lett 1999; 442: 147–150.
  CAS PubMed Google Scholar
• Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 2000; 289: 2350–2354.
  CAS PubMed PubMed Central Google Scholar
• Evans PC Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 2004; 378: 727–734.
  PubMed Google Scholar
• Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L Seshagiri S et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004; 430: 694–699.
  CAS PubMed Google Scholar
• Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5: 1052–1060.
  CAS PubMed Google Scholar
• Shembade N, Ma A, Harhaj EW . Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010; 327: 1135–1139.
  CAS PubMed PubMed Central Google Scholar
• Bosanac I, Wertz IE, Pan B, Yu C, Kusam S, Lam C et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell 2010; 40: 548–557.
  CAS PubMed Google Scholar
• Li L, Soetandyo N, Wang Q, Ye Y . The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim Biophys Acta 2009; 1793: 346–353.
  CAS PubMed Google Scholar
• Klinkenberg M, van Huffel S, Heyninck K, Beyaert R . Functional redundancy of the zinc fingers of A20 for inhibition of NF-κB activation and protein-protein interactions. FEBS Lett 2001; 498: 93–97.
  CAS PubMed Google Scholar
• Skaug B, Chen J, Du F, He J, Ma A, Chen ZJ . Direct, Noncatalytic Mechanism of IKK Inhibition by A20. Mol Cell 2011; 44: 559–571.
  CAS PubMed PubMed Central Google Scholar
• Tewari M, Wolf FW, Seldin MF, O'Shea KS, Dixit VM, Turka LA . Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J Immunol 1995; 154: 1699–1706.
  CAS PubMed Google Scholar
• Turer EE, Tavares R, Hitotsumatsu O, Advincula R, Lee BL, Shifrin N et al. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J Exp Med 2008; 205: 451–464.
  CAS PubMed PubMed Central Google Scholar
• Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, Rhee L et al. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 2010; 33: 181–191.
  CAS PubMed PubMed Central Google Scholar
• Chu Y, Vahl JC, Kumar D, Heger K, Bertossi A, Wójtowicz E et al. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 2011; 117: 2227–2236.
  CAS PubMed Google Scholar
• Hovelmeyer N, Reissig S, Xuan NT, Adams-Quack P, Lukas D, Nikolaev A et al. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 2011; 41: 595–601.
  PubMed Google Scholar
• Hammer GE, Turer EE, Taylor KE, Fang CJ, Advincula R, Oshima S et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol 2011; 12: 1184–1193.
  CAS PubMed PubMed Central Google Scholar
• Kool M, van Loo G, Waelput W, de Prijck S, Muskens F, Sze M et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 2011; 35: 82–96.
  CAS PubMed Google Scholar
• Song XT, Evel-Kabler K, Rollins L, Aldrich M, Huang XF, Chen SY . A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med 2008; 14: 258–265.
  CAS PubMed PubMed Central Google Scholar
• Arsenescu R, Bruno ME, Rogier EW, Stefka AT, McMahan AE, Wright TB et al. Signature biomarkers in Crohn's disease: toward a molecular classification. Mucosal Immunol 2008; 1: 399–411.
  CAS PubMed Google Scholar
• Vereecke L, Sze M, Mc Guire C, Rogiers B, Chu Y, Schmidt-Supprian M et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med 2010; 207: 1513–1523.
  CAS PubMed PubMed Central Google Scholar
• Kolodziej LE, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M et al. TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS ONE 2011; 6: e26352.
  CAS PubMed PubMed Central Google Scholar
• Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 2011; 43: 908–912.
  CAS PubMed Google Scholar
• Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216–1223.
  CAS PubMed PubMed Central Google Scholar
• Lippens S, Lefebvre S, Gilbert B, Sze M, Devos M, Verhelst K et al. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 2011; 18: 1845–1853.
  CAS PubMed PubMed Central Google Scholar
• Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Núñez G et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation. EMBO J 2008; 27: 373–383.
  CAS PubMed Google Scholar
• Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 2008; 28: 381–390.
  CAS PubMed PubMed Central Google Scholar
• Blonska M, Lin X . NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res 2011; 21: 55–70.
  CAS PubMed Google Scholar
• Duwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U et al. A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains. J Immunol 2009; 182: 7718–7728.
  PubMed Google Scholar
• Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat Immunol 2008; 9: 263–271.
  CAS PubMed Google Scholar
• Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D . Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 2009; 10: 466–473.
  CAS PubMed PubMed Central Google Scholar
• Gachon F, Peleraux A, Thebault S, Dick J, Lemasson I, Devaux C et al. CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J Virol 1998; 72: 8332–8337.
  CAS PubMed PubMed Central Google Scholar
• de Valck D, Jin DY, Heyninck K, van de Craen M, Contreras R, Fiers W et al. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 1999; 18: 4182–4190.
  CAS PubMed Google Scholar
• Ling L, Goeddel DV . T6BP, a TRAF6-interacting protein involved in IL-1 signaling. Proc Natl Acad Sci USA 2000; 97: 9567–9572.
  CAS PubMed PubMed Central Google Scholar
• Iha H, Peloponese JM, Verstrepen L, Zapart G, Ikeda F, Smith CD et al. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation. EMBO J 2008; 27: 629–641.
  CAS PubMed PubMed Central Google Scholar
• Shembade N, Harhaj NS, Liebl DJ, Harhaj EW . Essential role for TAX1BP1 in the termination of TNF-α-, IL-1- and LPS-mediated NF-κB and JNK signaling. EMBO J 2007; 26: 3910–3922.
  CAS PubMed PubMed Central Google Scholar
• Kitching R, Wong MJ, Koehler D, Burger AM, Landberg G, Gish G et al. The RING-H2 protein RNF11 is differentially expressed in breast tumours and interacts with HECT-type E3 ligases. Biochim Biophys Acta 2003; 1639: 104–112.
  CAS PubMed Google Scholar
• Sudol M, Chen HI, Bougeret C, Einbond A, Bork P . Characterization of a novel protein-binding module—the WW domain. FEBS Lett 1995; 369: 67–71.
  CAS PubMed Google Scholar
• Shembade N, Harhaj NS, Parvatiyar K, Copeland NG, Jenkins NA, Matesic LE et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol 2008; 9: 254–262.
  CAS PubMed Google Scholar
• Matesic LE, Copeland NG, Jenkins NA . Itchy mice: the identification of a new pathway for the development of autoimmunity. Curr Top Microbiol Immunol 2008; 321: 185–200.
  CAS PubMed Google Scholar
• Subramaniam V, Li H, Wong M, Kitching R, Attisano L, Wrana J et al. The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer 2003; 89: 1538–1544.
  CAS PubMed PubMed Central Google Scholar
• Azmi P, Seth A . RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation. Eur J Cancer 2005; 41: 2549–2560.
  CAS PubMed Google Scholar
• Santonico E, Belleudi F, Panni S, Torrisi MR, Cesareni G, Castagnoli L . Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment. Oncogene 2010; 29: 5604–5618.
  CAS PubMed Google Scholar
• Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A et al. Functional proteomics mapping of a human signaling pathway. Genome Res 2004; 14: 1324–1332.
  CAS PubMed PubMed Central Google Scholar
• Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW . The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling. EMBO J 2009; 28: 513–522.
  CAS PubMed PubMed Central Google Scholar
• Heyninck K, Kreike MM, Beyaert R . Structure-function analysis of the A20-binding inhibitor of NF-κB activation, ABIN-1. FEBS Lett 2003; 536: 135–140.
  CAS PubMed Google Scholar
• Mauro C, Pacifico F, Lavorgna A, Mellone S, Iannetti A . ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J Biol Chem 2006; 281: 18482–18488.
  CAS PubMed Google Scholar
• Oshima S, Turer EE, Callahan JA, Chai S, Advincula R, Barrera J et al. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 2009; 457: 906–909.
  CAS PubMed Google Scholar
• Zhou J, Wu R, High AA, Slaughter CA, Finkelstein D, Rehg JE et al. A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. Proc Natl Acad Sci USA 2011; 108: E998–E1006.
  CAS PubMed PubMed Central Google Scholar
• Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Löhr F et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins. Oncogene 2008; 27: 3739–3745.
  CAS PubMed Google Scholar
• Nanda SK, Venigalla RK, Ordureau A, Patterson-Kane JC, Powell DW, Toth R et al. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 2011; 208: 1215–1228.
  CAS PubMed PubMed Central Google Scholar
• Vincenz C, Dixit VM . 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 1996; 271: 20029–20034.
  CAS PubMed Google Scholar
• de Valck D, Heyninck K, van Criekinge W, Vandenabeele P, Fiers W, Beyaert R . A20 inhibits NF-κB activation independently of binding to 14-3-3 proteins. Biochem Biophys Res Commun 1997; 238: 590–594.
  CAS PubMed Google Scholar
• Bohgaki M, Tsukiyama T, Nakajima A, Maruyama S, Watanabe M, Koike T et al. Involvement of Ymer in suppression of NF-κB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim Biophys Acta 2008; 1783: 826–837.
  CAS PubMed Google Scholar
• Shembade N, Pujari R, Harhaj NS, Abbott DW, Harhaj EW . The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1. Nat Immunol 2011; 12: 834–843.
  CAS PubMed PubMed Central Google Scholar
• Lawrence T, Bebien M, Liu GY, Nizet V, Karin M . IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 2005; 434: 1138–1143.
  CAS PubMed Google Scholar
• Li Q, Lu Q, Bottero V, Estepa G, Morrison L, Mercurio F et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1). Proc Natl Acad Sci USA 2005; 102: 12425–12430.
  CAS PubMed PubMed Central Google Scholar
• Hutti JE, Abbott DW, Zhou AY, Sprott KM, Asara JM, Hahn WC . IKKβ Phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-κB pathway. Mol Cell Biol 2007; 27: 7451–7461.
  CAS PubMed PubMed Central Google Scholar
• Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature 2009; 459: 717–721.
  CAS PubMed PubMed Central Google Scholar
• Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009; 459: 712–716.
  CAS PubMed Google Scholar
• Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009; 114: 246–275.
  Google Scholar
• Chanudet E, Huang Y, Ichimura K, Dong G, Hamoudi RA, Radford J et al. A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 2010; 24: 483–487.
  CAS PubMed Google Scholar
• Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009; 206: 981–989.
  CAS PubMed PubMed Central Google Scholar
• Braun FC, Grabarczyk P, Möbs M, Braun FK, Eberle J, Beyer M et al. Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome. Leukemia 2011; 25: 1494–1501.
  CAS PubMed Google Scholar
• Ferch U, Kloo B, Gewies A, Pfänder V, Düwel M, Peschel C et al. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2009; 206: 2313–2320.
  CAS PubMed PubMed Central Google Scholar
• Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, Cohen PA . A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene 2007; 26: 4656–4667.
  CAS PubMed Google Scholar
• Guo Q, Dong H, Liu X, Wang C, Liu N, Zhang J et al. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target. Expert Opin Ther Targets 2009; 13: 733–741.
  CAS PubMed Google Scholar
• Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 2010; 8: e1000319.
  PubMed PubMed Central Google Scholar
• Sun SC . Deubiquitylation and regulation of the immune response. Nat Rev Immunol 2008; 8: 501–511.
  CAS PubMed PubMed Central Google Scholar
• Ahmed N, Zeng M, Sinha I, Polin L, Wei WZ, Rathinam C et al. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat Immunol 2011; 12: 1176–1183.
  CAS PubMed PubMed Central Google Scholar